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Obstructive sleep apnea is increasingly recognized as an important contributor to cognitive
impairment, metabolic derangements, and cardiovascular disease and mortality. Identify-
ing the mechanisms by which this prevalent disorder influences health outcomes is now
of utmost importance. As the prevalence of this disorder steadily increases, therapies are
needed to prevent or reverse sleep apnea morbidities now more than ever before. Oxida-
tive stress is implicated in cardiovascular morbidities of sleep apnea. What role oxidative
stress plays in neural injury and cognitive impairments has been difficult to understand
without readily accessible tissue to biopsy in persons with and without sleep apnea. An
improved understanding of the role oxidative stress plays in neural injury in sleep apnea
may be developed by integrating information gained examining neural tissue in animal mod-
els of sleep apnea with key features of redox biochemistry and clinical sleep apnea studies
where extra-neuronal oxidative stress characterizations have been performed. Collectively,
this information sets the stage for developing and testing novel therapeutic approaches
to treat and prevent, not only central nervous system injury and dysfunction in sleep
apnea, but also the cardiovascular and potentially metabolic conditions associated with
this prevalent, disabling disorder.
Keywords: neurons, obstructive sleep apnea, superoxide, redox regulation, carbonylation, cardiovascular diseases,
intermittent hypoxia
INTRODUCTION
Obstructive sleep apnea (OSA) syndromeis defined by the regu-
lar occurrence of episodic sleep state-dependent collapse of the
upper airway resulting in disturbed ventilation and sleep. When
ventilation ceases for greater than 10 s, the event is termed an
apnea. When ventilation continues, but is reduced and associated
with a significant decline in arterial oxygen saturation, the event is
termed a hypopnea. Severity of the disorder is characterized by the
frequency of apneas and hypopneas per hour of sleep; this measure
is termed the apnea/hypopnea index. The cardinal features of the
disorder, although not always present, are loud snoring with spo-
radic gasps in sleep associated with daytime sleepiness/fatigue or
simply unrefreshed sleep. OSA is a common disorder in developed
countries. Young et al. (1993) reported that approximately 4% of
males and 2% of females have an apnea-hypopnea index greater
than five events per hour of sleep combined with daytime exces-
sive sleepiness. Using newer definitions for apneas and hypopneas,
Duran et al. (2001) studied a 30–70 year old population-based
sample and found an apnea/hypopnea index >15/h in 7% of
women and 14% of males. There is a clear age-dependency for
OSA in both females and males. In females the prevalence for
OSA increases from 3% for the third decade of life to 36% in
the seventh decade (Tufik et al., 2010). In men the prevalence
for the third decade is 4% and increases to 50% for the sev-
enth decade (Tufik et al., 2010). Although not all individuals with
OSA are overweight, the vast majority of patients with OSA are
obese (Millman et al., 1991). Obesity raises the prevalence in all
groups. In children obesity increases the prevalence of OSA by
over fourfold (Redline et al., 1999). This overlap of obesity and
OSA in the majority of patients has made it more challenging
to identify OSA vs. obesity contributions to cardiovascular and
metabolic morbidities and is discussed below. Increased adiposity
of obesity not only increases soft tissue volume within the upper
airway, but also adds weight to the neck, further increasing airway
collapsibility. In addition, central obesity reduces lung volumes
which also promotes upper airway collapse. In addition to obesity,
there are craniofacial features that predispose to upper airway col-
lapse and OSA. For example both hypothyroidism and acromegaly
result in increased upper airway soft tissue and OSA (Veasey,
2010). In addition, long-term allergic rhinitis, enlarged tonsillar-
adenoid lymphoid tissue, nasal septal deformities, maxillary or
mandibular insufficiency all impose increased collapsibility on
the upper airway (Riha et al., 2009). Craniofacial syndromes with
any of these features, for example Down’s, Apert’s, and Treacher
Collins’ syndromes have increased prevalences of OSA (Katz et al.,
2012).
The common underlying pathophysiology of OSA is a sleep
state-dependent partial or complete collapse of the upper air-
way, resulting in brief interruptions in ventilation. In wakeful-
ness, upper airway dilator muscles are activated to stent open
the pharynx and hypopharynx in individuals with highly collapsi-
ble airways (Dempsey et al., 2010). Obstructive sleep-disordered
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FIGURE 1 | Sources of reactive oxygen and nitrogen species involved in
signaling and injury pathways. Major sources of reactive oxygen species
(ROS) identified in models of obstructive sleep apnea oxygenation include
mitochondria, the endoplasmic reticulum, and NADPH oxidase. Whether
xanthine oxidase and other oxidases or oxygenases also contributes to
oxidative injury in sleep apnea oxygenation models requires further study.
Nitric oxide synthases are also influenced by sleep apnea oxygenation
patterns. These ROS and RNS sources may be activated for healthy signaling
to increase superoxide (O2−•) nitric oxide (NO) and hydrogen peroxide (H2O2).
When these molecules are not rapidly cleared, hypochlorite (OCl−), hydroxyl
(OH•) and peroxynitrite (ONOO−) radicals can develop. These highly reactive
molecules are more likely to cause end-organ damage. Comprehensive
examination of end-organ oxidative stress damage requires characterization of
oxidative DNA damage, carbonyl, nitration, and lipid peroxidation measures.
breathing events occur because of normal sleep state-dependent
reductions in activity, including the activity of upper airway dila-
tors. Reduced dilator muscle tone combined with negative intra-
luminal pressures in the upper airway across inspiration result
in upper airway collapse, with attendant hypoxemia and hyper-
capnia. The degree of hypoxemia relates directly to ventilatory
responsiveness to both hypercapnia and hypoxia and also to end
expiratory lung volume. Because of increased weight upon the
abdomen and thorax, obese individuals will have smaller end expi-
ratory lung volumes in sleep and therefore, more rapid declines in
oxyhemoglobin desaturations. Both the hypoxemia and hyper-
capnia increase sympathetic output adding resistive load onto
the heart. Attempts to inspire with an occluded upper airway
result in large negative intrathoracic pressure swings, reducing car-
diac preload, and increasing cardiac afterload. Coupled with the
increased vascular resistance from the higher sympathetic drive
cardiac output declines until the individuals arouses, restoring
upper airway dilator muscle activity, airway patency, oxygen, and
carbon dioxide levels. Each event then repeats a brief cycle of inter-
mittent hypoxia, hypercapnia, sleep fragmentation, and arterial
perfusion instability. What is unique to OSA is that these obstruc-
tive ventilatory disturbances occur only in sleep and individual
events are quite brief, typically lasting less than 1 min. Of all of
the above listed physiological perturbances, it is this frequently
repeated hypoxia/reoxygenation that led investigators to exam-
ine the role of oxidative stress in OSA morbidities. This review
provides the basic redox biochemistry necessary to accurately
interpret the results obtained in previous OSA and oxidative stress
studies and then integrates findings in animal models of sleep
apnea oxygenation, where brain tissue has been examined with
human studies where peripheral measures of redox have been
analyzed.
BIOCHEMISTRY OF REACTIVE OXYGEN AND NITROGEN
SPECIES
Upon first glance at the intricacies of pathways and seemingly
countless molecules involved in oxidative modifications of pro-
teins, lipoproteins, and lipids, renders understanding redox bio-
chemistry a daunting task. But it need not be so. There are really
just a few definitions to understand and several key endpoint
oxidative modifications on the other end of the pathways to pro-
vide a knowledge base sufficient to understand oxidative injuries in
OSA and interpret the seemingly contradictory results of previous
studies. Reactive oxygen species (ROS) include superoxide (O2−•),
hydrogen peroxide (H2O2), hydroxyl radical (OH−•), hydroxyl
ion (OH−), and hypochlorite ion (OCl−•). Not all ROS are free
radicals; electrons are paired in both H2O2 and OH−. OH−• is the
most reactive and can impart significant oxidative damage. There
is a span of reactive nitrogen species ranging in low to high oxi-
dized state from N2O to NO− to NO to NO+ /NO2− to N2O3 to
NO2 to ONOO− (peroxynitrite) to N2O4 to NO3− (Gow, 2006).
HEALTHY OXIDATIVE SIGNALING
To begin to understand oxidative stress, it is first important to
recognize that certain ROS, e.g., O2−• and H2O2 and reactive
nitrogen species, e.g., nitric oxide (NO) are important signaling
molecules for adaptive, learning, and growth responses as illus-
trated in Figure 1. O2−• is essential for immunity, for killing
specific bacteria and fungi. In the central nervous system, increased
scavenging of ROS prevents hippocampal long-term potentiation
that is necessary to consolidate spatial memory after learning trials
(Klann, 1998). At the same time, too much O2−•, prevents long-
term potentiation in the hippocampus (Gahtan et al., 1998). How
can the same molecule be both adaptive and injurious? Reactive by
nature, O2− , H2O2, and NO will have extremely localized effects,
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unless produced at excessive rates when these molecules may inter-
act with a different subset of enzymes. For long-term potentiation,
O2− and H2O2 interact with calcium/calmodulin kinase II, pro-
tein kinase C, extracellular signal-related kinase, and calmodulin.
When these ROS are produced at higher rates or are less consumed,
they may inhibit calcineurin and inhibit long-term potentiation
(Ferri et al., 2000). This is one mechanism by which both aging
and Alzheimer’s may impair cognition (Agbas et al., 2005; Celsi
et al., 2007). NO plays an important role in adaptive vasodilating
responses in the peripheral vasculature and in neuronal signal-
ing, where in both systems, NO serves to increase cyclic guanosine
3′,5′-(cyclic) phosphate (cGMP; Neo et al., 2010; Vincent, 2010).
CELLULAR SOURCES OF OXIDATIVE STRESS
MITOCHONDRIA
In most cells, including neurons and glia, mitochondria are con-
sidered to be a major source of ROS. O2−• is a normal byproduct
in ATP production at complexes I and III along the electron trans-
port chain. In fact 1–4% of oxygen consumed will be converted
into O2− • . Under healthy conditions, the O2−• is converted to
H2O2 by SOD2 and then to H2O by glutathione peroxidase in the
mitochondria or by catalase if it enters the cytoplasm. Mitochondr-
ial redox homeostasis is very tightly regulated, where mechanisms
of mitochondrial redox regulation are only now being discovered.
In mammals, seated right at complex I is sirtuin 3 (SirT3). This
NAD+-dependent deacetylase is activated by increased energy
need and serves to activate complex I (Ahn et al., 2008) and at
the same time SirT3 initiates an impressive antioxidant response,
(Bell and Guarente, 2011). SirT3 increases reduced glutathione
by activating both isocitrate dehydrogenase 2 and glutathione
dehydrogenase (Someya et al., 2010; Yu et al., 2012). For added
mitochondrial protection, SirT3 activates Fox03a to increase tran-
scription of both superoxide dismutase isoform 2 (SOD2) and
catalase and directly activates SOD2 (Qiu et al.,2010). The adaptive
SirT3 response diminishes with advanced aging and contributes to
age-dependent hearing loss. Indeed, the ability of caloric restric-
tion to reduce oxidative stress and promote survival in auditory
neurons is completely dependent on SirT3 (Someya et al., 2010).
Thus, SirT3 is an example of an antioxidant regulator that targets
not just one component of the antioxidant response but numer-
ous components. Understanding the molecules with far reaching
effects on redox responses will provide more effective therapies
against oxidative damage. As mentioned above Complex III also
contributes to the formation of ROS and under hypoxic condi-
tions, where ubiquinone reduction products are major sources of
ROS. Finally, ROS may be produced in the mitochondria outside
the electron transport chain, within the Krebs cycle by an enzyme,
alpha-ketoglutarate dehydrogenase (Tretter and Adam-Vizi,2004).
Whether Sirt3 directly influences these latter two sources of ROS
will be important to discern in future studies, but it is also impor-
tant to understand that SirT3 transcription itself may be inhibited
by high amounts of ROS (D’Aquila et al., 2012).
ENDOPLASMIC RETICULUM
One of the most oxidative environments in the cell is within
the lumen of the endoplasmic reticulum (ER), where the highly
oxidative environment is necessary for the formation of specific
disulfide bonds in protein folding, essential for a protein’s activ-
ity. In health, disulfide formation is tightly regulated by protein
disulfide isomerases, and is prevented from randomly occurring
in this highly oxidative environment by chaperones. The primary
functions of the ER are to process and fold proteins. Pathophysi-
ological conditions, such as OSA, diabetes, aging, and obesity, can
lead to increased misfolded proteins in the ER, overwhelming the
availability of chaperones, thereby causing further protein mis-
folding with improper disulfide bonds (Malhotra et al., 2008). A
vicious cycle may be set in these conditions as oxidative modifi-
cations in proteins from the underlying disease result in protein
misfolding and then require greater ER re-folding activities and
thus greater oxidative stress. Severe ER oxidative stress results in
calcium release into the cytoplasm, that, in turn, increases oxidative
stress in the mitochondria through many of the mechanisms listed
above in mitochondrial sources of ROS. Increased ROS in the ER
also depletes reduced glutathione further compounding oxidative
stress. This ER and mitochondrial oxidative stress crosstalk sets
up a second vicious cycle where oxidative stress in one organelle
facilitates the development in a second.
ROS AND RNS GENERATING ENZYMES
Within many eukaryotic cells, including neurons and glia there
are numerous oxidases and oxygenases that can contribute to
increased bioavailability of ROS and RNS. One of the most promi-
nent is NADPH oxidase (Nox). NADPH oxidase directly increases
O2−• and may play a central role in activating other sources of
O2−•, including mitochondria (via opening mitochondrial tran-
sition pore), xanthine oxidase, but activating xanthine oxidase and
RNS by uncoupling both endothelial nitric oxide synthase (eNOS)
and neuronal nitric oxide synthase (nNOS; Ago et al., 2011). Nox2
is prominent in the brain and can be activated by angiotensin II,
protein kinase C activation, and by increased intracellular calcium.
Herein lies another vicious cycle in that increased intracellular
calcium will activate both mitochondrial and NADPH oxidase
sources of O2−•, resulting in more ER stress and more intra-
cellular calcium. eNOS activation can sequester O2−• through
production of ONOO− and is believed to play a largely protective
role until oxidative stress suppresses its activity via oxidizing its
co-factor BH4.
CONSIDERATIONS OF REDOX ASSAYS
One of the many challenges in oxidative stress research is the vast
number of possible assays available with which to characterize
oxidative stress. This can be simplified by considering what the
different assays measure. In general the assays fall into several
groups: RNA and DNA damage, lipid peroxidation, protein nitra-
tion, protein oxidation, and the presence of ROS. Some of the more
commonly used ROS assays for nucleic acid modifications include
8-hydroxyguanosine (8-OHG) and 8-hydroxydeoxyguanosine (8-
OHdG), both of which can be measured in tissue, blood, and urine.
The gold standard for lipid peroxidation is mass spectroscopy
for 8-isoprostanes, but 4-hydroxynonenal (4-HNE), malondialde-
hyde (MDA), and thiobarbituric acid reactive substances (TBARS)
are also used. 4-HNE cannot be sampled in urine, while others
can. Protein oxidation is measured as total protein carbonyl by
ELISA or westerns, and 3-nitrotyrosine is used to characterize
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nitration of proteins, also by westerns and ELISA. Dihydroethi-
dine allows histological examination of superoxide availability, as
described below in animal studies (Nguyen et al., 2003). There
are many newer in vivo fluorescent reporters for ROS that will
allow subcellular localization of mitochondria or ER ROS pro-
duction. Additionally, examination of NO availability can be used
as an index of superoxide availability. One of the newer techniques
being optimized for more direct measurement of ROS, RNS, and
oxygen is electron paramagnetic resonance (EPR) spectroscopy
(Mrakic-Sposta et al., 2012). EPR may be used for plasma, tissue
culture, and even in vivo experiments. The technique is sensitive
enough to detect exercised-induced ROS in the plasma of healthy
adults, and values correlate very closely with TBARS and carbonyl
protein levels (Mrakic-Sposta et al., 2012).
There are several important considerations when selecting
oxidative stress measures to characterize OSA redox. Examination
of total proteins will include long-lasting proteins with cumulative
redox changes and short-lived proteins with most recent changes.
In sleep apnea, it would be helpful to identify proteins with very
rapid turnover to allow measures before and after sleep or before
and after a night of therapy. Conversely, examination of long-
lasting proteins allows a long-term snapshot of oxidative status.
It is hoped that future studies will parcel out for analysis sev-
eral short-lived proteins susceptible to nitration and/or oxidation
changes and several proteins susceptible to long-term cumulative
oxidative and nitrative changes.
EVIDENCE FOR NEURONAL OXIDATIVE STRESS IN ANIMAL
MODELS OF OSA
REDOX ALTERATIONS ASSOCIATED WITH NEURONAL INJURY OR
DYSFUNCTION
Although many of the physiological perturbations described in
the above Introduction have the potential to increase the bioavail-
ability of ROS and RNS, the best-studied challenge in animal
models is intermittent hypoxia, modeling the patterns of severe
OSA arterial oxygenation. It is important to recognize that mild,
brief episodes of intermittent hypoxia may actually be good for
the brain. Mitchell and colleagues have shown that exposure to
<1 h of mild intermittent hypoxia increases long-term facilitation
of the phrenic and hypoglossal nerves and promotes increased
growth after spinal cord injury (Baker and Mitchell, 2000; Lovett-
Barr et al., 2012). Long-lasting more frequent episodes, however,
clearly result in neuronal injury and cognitive dysfunction (Gozal
et al., 2001). There are areas of the brain that are more sus-
ceptible to this long-term intermittent hypoxia (LTIH) injury,
namely pyramidal neurons in the cerebral and hippocampal cor-
tices, Purkinje neurons, catecholaminergic wake-active neurons,
and motoneurons, particularly trigeminal, facial, and hypoglos-
sal motoneurons (Gozal et al., 2001; Veasey et al., 2004a,b; Pae
et al., 2005). Carbonylated proteins, tyrosine nitration, and lipid
peroxidation are all found in the brains of animals exposed to
LTIH (Veasey et al., 2004a,b). In each of these groups it appears
that superoxide contributes to injury or neuronal dysfunction
because superoxide dismutase mimetics administered through-
out the LTIH exposure can prevent or substantially reduce injury
or dysfunction (Peng and Prabhakar, 2003; Veasey et al., 2004b).
A newer technique applied by Douglas et al. (2010) allows a look
at superoxide availability. Injected systemically, dihyroethidine is
readily taken up in all cell bodies and nuclei. In the presence of
superoxide radical, dihydroethidine converts to autofluorescent
dihydroethidium/ethidium that may be analyzed by fluorescent
microscopy. Douglas et al. (2010) found increased superoxide rad-
ical availability in cortical neurons of newborn mice exposed to
intermittent hypoxia.
NADPH OXIDASE NEURAL INJURY IN LTIH
The differential in vulnerability across groups of wake neurons
led to the discovery that NADPH oxidase subtype 2 (Nox2) is a
major source of oxidative injury (Zhan et al., 2005). Since this
initial discovery, NADPH oxidase has been shown to contribute
to LTIH hippocampal and cortical injury (Yuan et al., 2008; Nair
et al., 2011). Of great clinical significance, NADPH oxidase is also
implicated in many LTIH vascular injuries or conditions, including
hypertension, cardiac remodeling, and pulmonary hypertension
(Hayashi et al., 2008; Khan et al., 2011). Thus, NADPH oxidase
may be an excellent pharmacological target for preventing and
treating neuronal and vascular injuries secondary to intermittent
hypoxia in OSA.
MITOCHONDRIAL INJURY IN LTIH
In addition to NADPH oxidase injuries, mitochondria are injured
in model of LTIH. Mitochondria are a source of ROS in in vitro
models of LTIH (Peng and Prabhakar, 2003). As the mitochon-
drial isoform of superoxide dismutase (SOD2) prevents cortical
neuronal injury (Shan et al., 2007), mitochondria must also be
an important source of ROS in LTIH. Douglas et al. (2010) have
shown that mitochondrial dysfunction precedes oxidative stress
in a model of LTIH with intermittent hypercapnia. The source of
mitochondrial dysfunction in LTIH is not known. Whether mito-
chondrial injury results in NADPH oxidase activation or vice versa
will be important to examine to identify the optimal targets for
antioxidant therapies in OSA.
ER STRESS INJURY IN LTIH
Our lab has recently examined the role of ER stress in LTIH
motoneuron injury, finding that the unfolded protein response
is activated in hypoglossal and facial motoneurons by LTIH and
that this results in severe ER stress with upregulation of the
C/EBP homologous binding protein (CHOP; Zhu et al., 2008).
In LTIH CHOP increases oxidative stress by upregulating an ER
oxidase (ERO-1), hypoxia-inducible factor-1a, and NADPH oxi-
dase (Nox2; Chou et al., in press). Whether CHOP influences
mitochondrial release of ROS should now be examined.
XANTHINE OXIDASE IN ISCHEMIC INJURY
Xanthine oxidase is an important source of oxidative stress in
reperfusion injuries to the brain and heart. Whether xanthine oxi-
dase inhibitors are effective in reducing neuronal injury in LTIH
has not been reported. Xanthine oxidase inhibition does not always
prevent or modify ischemic injury (Arai et al., 1998) and can how-
ever have detrimental effects including lowering NADH in the
brain (Al-Gonaiah et al., 2009). Peripherally, there is evidence
that xanthine oxidase contributes to endothelial dysfunction in
LTIH and then administration of allopurinol, a xanthine oxidase
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inhibitor, can reduce LTIH oxidative stress (Williams et al., 2010;
Dopp et al., 2011).
In summary, oxidative stress is clearly an important contributor
to neuronal injury in LTIH animal models of OSA oxygena-
tion. Whether the other physiological perturbations including
hemodynamic changes, sleep fragmentation, and carbon dioxide
fluctuations also modify ROS production should be examined.
In LTIH, NADPH oxidase, mitochondria, and ER stress are all
involved in ROS generation. Reducing one source does influence
other sources, but the optimal combination still eludes us and must
be confirmed to improve mitochondrial function. As we move for-
ward to advance therapeutics to reduce neuronal injury in OSA, we
will need to consider the role of ROS in cardiovascular morbidities
as well.
PERIPHERAL OXIDATIVE STRESS IN HUMAN OSA
EVIDENCE FOR LIPID PEROXIDATION IN OSA
There have been many clinical studies examining lipid peroxi-
dation in OSA. Some of the challenges in these studies small
sample sizes (inadequate statistical power) and include subjects
with confounding co-morbidities, e.g., obesity and cigarette smok-
ing, that were not always matched across groups (Barcelo et al.,
2000; Ozturk et al., 2003). Lavie et al. (2004) examined TBARS in
114 patients with OSA and cardiovascular disease and compared
levels to 55 patients with cardiovascular disease but without OSA.
TBARS in OSA, relative to non-OSA, subjects was twice as high
before and after sleep, suggesting a sustained increase in lipid per-
oxidation from OSA without an acute increase from one night of
untreated OSA (Lavie et al., 2004). A positive correlation was found
for the severity of OSA and the TBARS value (Lavie et al., 2004).
Across a collection of subjects with moderate-severe OSA, plasma
MDA levels decrease with continuous positive airways pressure
(CPAP), but remain well above normal values (Jordan et al., 2006).
Svatikova et al. (2005) measured plasma TBARS and isoprostanes
in moderate-sever OSA subjects before and after 4 h of therapy
for OSA with CPAP and found no treatment effect. This duration
of therapy is not expected to affect total lipid peroxidation. In a
trial looking at MDA plasma levels in severe OSA patients before
and after 10 months of therapy, MDA levels fell significantly (Her-
nandez et al., 2006). An alternative therapy for mild OSA is an
oral mandibular advancement device that moves the lower jaw
forward; this therapy has also been shown to reduce MDA levels
(Itzhaki et al., 2007). Overall, it seems that OSA contributes to
elevated lipid peroxidation in individuals with moderate-severe
OSA. The absence of compete normalization of MDA levels with
effective therapy for OSA over sufficient time to replace many cells
contributing to plasma MDA levels, supports the concept that
the higher MDA in patients with OSA (but without pulmonary,
cardiac, or endocrine disorders) is in part a consequence of co-
morbid conditions, including obesity, high fatty diet, sedentary
lifestyle.
EVIDENCE FOR PROTEIN NITRATION IN OSA
Several studies have examined protein nitration also in plasma.
As with lipid peroxidation measures, in many studies details
are not provided as to how rapidly plasma was dissociated and
plasma frozen. This is a problem as substantial nitration and lipid
peroxidation may continue in unfrozen blood, plasma, and urine
samples. A recent study reported both lipid peroxidation and pro-
tein nitration levels in both exhaled breath condensates and plasma
for 35 patients with moderate-severe OSA (AHI> 15/h) before
and after 3 months therapy with CPAP. Exhaled breath condensate
nitration fell significantly from 17 to 5 pg/ml, p< 0.05, as did 8-
isoprostane levels, 6–3, p< 0.05. Larger changes were observed
for plasma values. In contrast c-reactive protein, interleukin-6
and tumor necrosis factor-a did not change significantly in this
group of patients with therapy (Karamanli et al., 2012). Jelic
and colleagues performed endothelial cell biopsies on individ-
uals with mild, moderate, and severe OSA and controls and
then used immunohistochemistry techniques on rapidly fixed
cells to measure nitration, eNOS, and iNOS. Subjects with OSA
had higher levels of nitrotyrosine and cyclooxygenase-2 (COX2)
and lower levels of eNOS. With CPAP therapy, nitrotyrosine
and COX2 levels normalized. This work strongly supports the
concept that OSA can increase nitration in cells, exhalate, and
plasma (Jelic et al., 2008). That therapy fully reverses nitra-
tion suggests that OSA itself is a primary contributor to protein
nitration.
EVIDENCE FOR INCREASED PROTEIN CARBONYLATION AND
SUPEROXIDE IN OSA
Protein carbonylation occurs hyperbolically across aging, but at a
great pace with prolonged oxidative stress. There have been sev-
eral studies examining protein carbonylation in OSA patients. In
one of the first carbonylation was examined in intercostals muscle
tissue (Barreiro et al., 2007). Consecutive patients were examined
in a clinic population without matching for health problems in
controls. Carbonyl levels were higher in OSA subjects; however,
values did not change with 6 months of effective CPAP therapy.
Thus, it is not clear whether OSA contributes to protein carbony-
lation in skeletal muscle. A second study reported serum carbonyl
levels across the spectrum of OSA patients findings a positive cor-
relation between AHI and serum carbonyl levels (Vatansever et al.,
2011). There is one study reporting improvements in plasma car-
bonyl levels with 3 months of CPAP therapy (Jurado-Gamez et al.,
2011). It is important to recognize that many structural proteins
in the brain exist for a lifetime and thus may accumulate car-
bonyl modifications over years, leading to progressive misfolding,
impaired function, highlighting the importance of early inter-
vention. There is one pilot EPR study examining the effect of
leptin administration on superoxide in plasma of OSA patients.
The study shows a dose-dependent response for leptin in low-
ering ROS (Macrea et al., 2012). The study lacks control groups
for comparison of basal ROS, but shows the promise of using
this technique to evaluate treatment effects on ROS in individuals
with OSA.
CIRCADIAN CONSIDERATIONS OF OSA AND OXIDATIVE
STRESS
A large body of research over the past few years has unveiled impor-
tant, albeit complex, relationships between the circadian system,
metabolics, and OSA. The prevalence of metabolic syndrome is
>10% in adults with OSA, and when patients with both OSA and
metabolic syndrome (without other co-morbidities) are treated
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effectively with CPAP, the metabolic derangements reverse suf-
ficiently to lower the prevalence of metabolic syndrome to 1%
in treated individuals (Sharma et al., 2011). At the cellular level
metabolics is primarily influenced by redox changes in nicoti-
namide adenine dinucleotide (NAD+) and flavin adenine dinu-
cleotide (FAD). Recently, one of the major enzymes involved in
NAD+ synthesis, NAMPT, was found to demonstrate a strong cir-
cadian rhythm (Nakahata et al., 2009; Ramsey et al., 2009). NAD+
influences the activity of SirT1 and SirT3 and, thus, is expected
to contribute to circadian rhythms of antioxidant enzymes. In
simpler life forms many antioxidant enzymes demonstrate circa-
dian rhythmicity (Yoshida et al., 2011). One of these antioxidant
enzymes, peroxiredoxin, shows circadian rhythmicity also in mice
(Edgar et al., 2012). Intriguingly, peroxiredoxin levels in the liver
and SCN of the mouse cycle 180˚ out of phase (Edgar et al.,
2012). Thus, we must consider patients’ circadian rhythmicity and
antioxidant rhythmicity within specific tissues as key variables in
assessing redox status in individuals with OSA, before and after
therapy.
CONCLUSION AND PROSPECTIVE
As the prevalence of obesity escalates worldwide, so does the
prevalence of OSA, including in children and young adults. In
children, OSA is linked to poor performance in school (Beebe
and Byars, 2011). In adults with OSA, impaired cognition is asso-
ciated with increase risk of motor vehicle accidents and poor
work performance (Shah et al., 2006). Many studies examining
cognitive performance and brain imaging studies in OSA show
improvements with therapy but incomplete resolution (Li and
Veasey, 2012). Studies in animal models of OSA oxygenation pat-
terns support oxidative injury as a major contributor to neuronal
injury in OSA, where NADPH oxidase activation and mitochon-
drial and ER dysfunction underlie the surge in ROS. Providing a
non-invasive whole organ or plasma measurement of ROS, fur-
ther refinement of EPR will provide a much-needed window into
oxidative stress in OSA and in animal models of the disorder.
In humans, such measures may be used to guide clinical thera-
peutic options in patients and to follow effectiveness of therapy.
ER and mitochondrial stress and HIF-1a upregulation clearly
underlie, at least in part, the oxidative stress. For example ER
stress protein CHOP is necessary for NADPH oxidation, ROS,
and HIF-1a activation and should be an excellent upstream tar-
get for the prevention of oxidative injury in OSA (Yuan et al.,
2008). It is clear from human OSA studies that similar mech-
anisms are at play in the periphery. Thus, the periphery may
provide a valuable window into the severity of OSA oxidative
stress in individual patients, potentially allowing therapeutic indi-
vidualization. For the numerous children and adults with OSA,
these steps must be taken expeditiously to minimize irreversible
injury.
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